Symbol="INFI"
AssetType="Common Stock"
Name="Infinity Pharmaceuticals Inc"
Description="Infinity Pharmaceuticals, Inc., a biopharmaceutical company, is focused on developing new drugs for people with cancer. The company is headquartered in Cambridge, Massachusetts."
CIK="1113148"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="784 MEMORIAL DRIVE, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="19419400"
EBITDA="-43502000"
PERatio="None"
PEGRatio="-0.05"
BookValue="-0.317"
DividendPerShare="0"
DividendYield="0"
EPS="-0.5"
RevenuePerShareTTM="0.03"
ProfitMargin="0"
OperatingMarginTTM="-16.45"
ReturnOnAssetsTTM="-0.536"
ReturnOnEquityTTM="-35.21"
RevenueTTM="2672000"
GrossProfitTTM="-31381000"
DilutedEPSTTM="-0.5"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.121"
AnalystTargetPrice="0.3"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="19.29"
PriceToBookRatio="8.03"
EVToRevenue="1.165"
EVToEBITDA="0.101"
Beta="1.427"
num_52WeekHigh="1.76"
num_52WeekLow="0.119"
num_50DayMovingAverage="0.182"
num_200DayMovingAverage="0.517"
SharesOutstanding="89905000"
DividendDate="None"
ExDividendDate="None"
symbol="INFI"
open="0.21"
high="0.23"
low="0.19"
price="0.22"
volume="755015.00"
latest_trading_day="2023-07-07"
previous_close="0.20"
change="0.02"
change_percent="8.0540%"
aroon_positive_momentum_days="19"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="19"
Volume_recent_avg="1006792"
Change_recent_avg="0.01"
Delta_recent_avg="0.02"
Variance_recent_avg="0.01"
Change_ratio_recent_avg="-0.62"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="19"
Aroon_momentum_negative="81"
image_negative_thumbnail_id_1="492"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0113.jpeg"
image_negative_thumbnail_id_2="1148"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0181.jpeg"
image_neutral_thumbnail_id_1="554"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0045.jpeg"
image_neutral_thumbnail_id_2="569"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0030.jpeg"
image_positive_thumbnail_id_1="643"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0065.jpeg"
image_positive_thumbnail_id_2="617"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0091.jpeg"
image_professor_thumbnail_id_1="1178"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
image_professor_thumbnail_id_2="1200"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
